Sparrow Pharmaceuticals, Inc.

Form D Filings

Location
Portland, OR
Industry Group
Pharmaceuticals
Entity Type
Corporation
CIK
0001786949
All SEC Filings
View on sec.gov
Date Filed Security Types Amount Sold Diff Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
7/1/2025 Equity $61,841,225 $61,841,225 $121,400,027 $59,558,802 6/20/2025 7/1/2025 D 000178694925000002
4/12/2024 Debt, Option to Acquire $10,000,000 $10,000,000 $15,251,730 $5,251,730 4/10/2024 4/12/2024 D 000178694924000002
1/13/2021 Equity $1,075,255 $1,075,255 $50,825,257 $49,750,002 12/31/2020 1/13/2021 D 000178694921000001
6/26/2020 Debt, Option to Acquire $67,500 $337,500 $337,500 $0 8/21/2018 6/25/2020 D/A 000178694920000001
11/15/2019 Debt, Option to Acquire $270,000 $270,000 $8,000,000 $7,730,000 8/21/2018 11/15/2019 D 000178694919000001